| Angela Leigh Pesik, MSN, FNP,ARNP | |
|
401 W Main St, Walla Walla, WA 99362-2837 | |
| (877) 522-1275 | |
| Not Available |
| Full Name | Angela Leigh Pesik |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 401 W Main St, Walla Walla, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225620099 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | AP61137102 (Washington) | Primary |
| 363LF0000X | Nurse Practitioner - Family | AP61137102 (Washington) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Leigh Pesik, MSN, FNP,ARNP 2201 S 3rd Ave, Walla Walla, WA 99362-4411 Ph: (509) 301-1540 | Angela Leigh Pesik, MSN, FNP,ARNP 401 W Main St, Walla Walla, WA 99362-2837 Ph: (877) 522-1275 |
News Archive
A new study published on the preprint server bioRxiv in October 2020 shows that vascular cells in the lung tissue begin to secrete signaling growth factors when exposed to just the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), without the rest of the viral components.
Amgen reported adjusted earnings per share (EPS) of $1.38 for the second quarter of 2010, an increase of 7 percent compared to $1.29 for the second quarter of 2009. Adjusted net income increased 1 percent to $1,326 million for the second quarter of 2010 compared to $1,311 million for the second quarter of 2009.
Researchers at the University of Zurich have discovered the identity of the stem-cell niche of the colon. The niche comprises special cells that activate the stem cells of the adjacent intestinal epithelium and are responsible for its continuous renewal.
PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).
› Verified 6 days ago
Patrick R Smart, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 401 W Poplar St, Sleep Medicine Center, Walla Walla, WA 99362 Phone: 509-522-5946 Fax: 509-522-5527 | |
Delila C Ojeda, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-522-0100 Fax: 509-527-8010 | |
Hyunjin Eo, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1017 S 2nd Ave Ste 1, Walla Walla, WA 99362 Phone: 509-398-9699 | |
Ms. Leikin Louise Patrick, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 380 Chase Ave, Walla Walla, WA 99362 Phone: 509-897-3333 | |
Emily Grace Castillo, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 Fax: 509-522-1593 | |
Mary Buriani, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-527-8151 Fax: 509-527-8010 | |
Susan D Collins, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1111 S 2nd Ave, Walla Walla, WA 99362 Phone: 509-522-0100 Fax: 509-527-8010 |